Evidence map›Paper›PMID 28974142›Full record

ArticleQualitative health research2017

Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.

Molly M Lynch, Jacqueline B Amoozegar, Emily M McClure, Linda B Squiers, Cheryl S Broussard, Jennifer N Lind, Kara N Polen, Meghan T Frey, Suzanne M Gilboa, Janis Biermann

Abstract read
In one paragraph

Article in Qualitative health research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. GPs' awareness of pregnancy: trends and association with hazardous medication use.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Molly M Lynch1 RTI International, Research Triangle Park, North Carolina, USA.
Jacqueline B Amoozegar1 RTI International, Research Triangle Park, North Carolina, USA.
Emily M McClure1 RTI International, Research Triangle Park, North Carolina, USA.
Linda B Squiers1 RTI International, Research Triangle Park, North Carolina, USA.
Cheryl S Broussard2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Jennifer N Lind2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Kara N Polen2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Meghan T Frey2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Suzanne M Gilboa2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Janis Biermann3 March of Dimes Foundation, White Plains, New York, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Our study sought to explore the actual and potential roles of patients, physicians, and pharmacists, as well as their shared challenges and opportunities, in improving the safety of medication use during pregnancy. We conducted virtual focus groups with 48 women and in-depth interviews with nine physicians and five pharmacists. Qualitative analysis revealed that all three groups of participants reported "playing it safe," the need for an engaged patient making informed decisions, challenges surrounding communication about pregnancy status, and a lack of patient-centric resources. Patients, physicians, and pharmacists are highly motivated to protect developing babies from potential harms of medication use during pregnancy while maintaining the patient's health. Strategic messaging could maximize the effectiveness of these interactions by helping physicians discuss the benefits and risks of medication use during pregnancy, pharmacists screen for pregnancy and counsel on medication safety, and patients using medications to share pregnancy intentions with their providers pre-pregnancy.

Indexed as

AdultCommunicationDecision MakingFemaleFocus GroupsHumansInformation Seeking BehaviorInterviews as TopicMaleNonprescription DrugsPatient Education as TopicPatient ParticipationPharmacistsPhysiciansPregnancyPregnant PeopleNonprescription DrugsPrescription Drugscommunicationdecision makingdoctor–patienteducationhealthinformation seekingnurse–patientpatientpregnancyqualitativereproductiontriangulationUnited States

Identifiers

PMID28974142
PMCPMC5819595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.